BOCCACCIO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 6.314
AS - Asia 3.882
EU - Europa 3.549
SA - Sud America 351
Continente sconosciuto - Info sul continente non disponibili 253
AF - Africa 58
OC - Oceania 46
Totale 14.453
Nazione #
US - Stati Uniti d'America 6.106
CN - Cina 1.551
IT - Italia 1.232
SG - Singapore 1.047
DE - Germania 394
VN - Vietnam 330
BR - Brasile 283
FR - Francia 281
IE - Irlanda 259
SE - Svezia 243
GB - Regno Unito 221
FI - Finlandia 217
JP - Giappone 180
KR - Corea 179
UA - Ucraina 161
HK - Hong Kong 141
CA - Canada 123
NL - Olanda 116
IN - India 114
PL - Polonia 69
ES - Italia 66
CH - Svizzera 56
BD - Bangladesh 53
BE - Belgio 48
ID - Indonesia 45
AU - Australia 41
MX - Messico 38
TW - Taiwan 37
RU - Federazione Russa 31
AT - Austria 30
IQ - Iraq 27
TR - Turchia 23
AR - Argentina 22
IR - Iran 21
RO - Romania 17
TH - Thailandia 17
IL - Israele 16
UZ - Uzbekistan 16
MY - Malesia 14
DK - Danimarca 13
CO - Colombia 12
JM - Giamaica 12
NO - Norvegia 12
PK - Pakistan 12
SA - Arabia Saudita 12
GR - Grecia 11
CZ - Repubblica Ceca 10
MA - Marocco 10
CR - Costa Rica 9
HU - Ungheria 9
ZA - Sudafrica 9
DZ - Algeria 8
EC - Ecuador 8
JO - Giordania 8
LT - Lituania 8
KZ - Kazakistan 7
RS - Serbia 7
PE - Perù 6
PT - Portogallo 6
SN - Senegal 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CL - Cile 5
EG - Egitto 5
PR - Porto Rico 5
PY - Paraguay 5
VE - Venezuela 5
GT - Guatemala 4
NZ - Nuova Zelanda 4
PH - Filippine 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
EE - Estonia 3
KE - Kenya 3
LB - Libano 3
LU - Lussemburgo 3
NP - Nepal 3
QA - Qatar 3
SI - Slovenia 3
UY - Uruguay 3
AM - Armenia 2
CG - Congo 2
DM - Dominica 2
DO - Repubblica Dominicana 2
EU - Europa 2
GL - Groenlandia 2
HN - Honduras 2
HR - Croazia 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 14.178
Città #
Singapore 584
San Jose 556
Chandler 542
Ashburn 437
Beijing 401
Ann Arbor 391
Santa Clara 381
Dublin 249
Milan 190
Shanghai 190
Fairfield 186
Houston 155
Turin 145
Ho Chi Minh City 122
Dearborn 108
Redwood City 106
The Dalles 105
Torino 100
Jacksonville 96
Wilmington 95
Princeton 87
Columbus 86
Woodbridge 86
Los Angeles 83
New York 83
Hong Kong 80
Seattle 80
Villeurbanne 80
Rome 79
Medford 78
Tokyo 73
Guangzhou 67
Hefei 67
Lauterbourg 64
Hanoi 63
Dallas 59
Cambridge 58
Helsinki 58
Warsaw 58
Munich 57
Nyköping 57
Seoul 57
Buffalo 52
Nanjing 50
Naples 45
Boston 42
Wuhan 40
Hangzhou 38
Pisa 37
Boardman 34
São Paulo 34
Chicago 31
Jakarta 30
Chengdu 29
Frankfurt am Main 29
Paris 27
Verona 27
Nuremberg 26
Fremont 25
Vienna 25
Brussels 24
Bengaluru 23
Changsha 23
London 23
San Diego 23
Council Bluffs 22
Dong Ket 22
Toronto 22
Amsterdam 20
Turku 20
Atlanta 19
Montreal 19
Shenyang 19
Genoa 18
Ottawa 18
Lappeenranta 17
Madrid 17
Washington 17
Taipei 16
Zhengzhou 16
Florence 15
Luni 15
Mexico City 15
Orem 15
Utrecht 15
Da Nang 14
Jinan 14
Manchester 14
Stockholm 14
Falls Church 13
Osaka 13
Redondo Beach 13
Tianjin 13
Xian 13
Baghdad 12
Bologna 12
Cossato 12
Phoenix 12
San Francisco 12
Shenzhen 12
Totale 7.986
Nome #
Known and novel roles of the MET oncogene in cancer: A coherent approach to targeted therapy 1.909
Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer 903
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 434
A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy 426
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 408
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor 385
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 367
The MET oncogene is a functional marker of a glioblastoma stem cell subtype. 312
MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors. 258
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition 250
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. 237
TNF-α promotes invasive growth through the MET signaling pathway. 219
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells 205
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma 205
MET-Mediated Resistance to EGFR Inhibitors: An Old Liaison Rooted in Colorectal Cancer Stem Cells. 204
A differentiation switch for genetically modified hepatocytes. 191
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 187
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. 171
HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity 171
Cancer and blood coagulation 170
The MET Oncogene in Glioblastoma Stem Cells: Implications as a Diagnostic Marker and a Therapeutic Target. 169
WHEN REGULATION FAILS: HOW CANCER ARISES 160
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 159
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 158
The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor 156
A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor 156
“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”? 154
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro 153
Ets up-regulates MET transcription 152
Ionizing radiation fosters cancer invasion through transcriptional up-regulation of the MET oncogene 151
ERBB3 as a therapeutic target in glioblastoma: overexpression can make the difference 150
A functional role for hemostasis in early cancer development 146
The MET oncogene drives a genetic programme linking cancer to haemostasis 144
Derivation and charaterization of cancer initialling cells representative of metastatic colorectal cancer genetic heterogeneity 143
Apoptosis enhancement by the HIV-1 Nef protein. 142
Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10. 134
I RECETTORI PER I FATTORI DI CRESCITA 127
Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. 127
Exploring the interplay between MET and Tumor Necrosis Factor alpha 125
Colorectal cancer stem cells, MET and metastasis 125
The long-lasting protective effect of HGF in cardiomyoblasts exposed to doxorubicin requires a positive feed-forward loop mediated by ERK1,2-TIMP1-STAT3 124
Hepatocyte growth factor is a regulator of monocyte-macrophage function 123
Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients’ management: Close to the clinic? 123
Invasive growth: a MET-driven genetic programme for cancer and stem cells 121
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) 119
I recettori per i fattori di crescita 119
Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. 119
I RECETTORI PER I FATTORI DI CRESCITA 114
Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription 112
I FATTORI DI CRESCITA CONTROLLANO LA PROLIFERAZIONE CELLULARE 109
The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. 109
Interactions between growth factor receptors and adhesion molecules: breaking the rules. 108
Protocol for in vitro establishment of heterogeneous stem-like cultures derived from whole human glioblastoma tumors 107
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells 107
Ligand-independent tyrosine phosphorylation of the receptor encoded by the c-neu oncogene. 105
GROWTH FACTORS AND CELL SIGNALLING 104
Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells 104
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary 103
The HGF receptor family: unconventional signal transducers for invasive cell growth. 101
The MET oncogene drives a genetic programme for stem and cancer cells 100
MET, a driver of invasive growth and cancer clonal evolution under therapeutic pressure. 100
MET∆14 promotes a ligand-dependent, AKT-driven invasive growth 99
Genetic link between cancer and thrombosis 96
Growth Factor Receptors 95
L'oncogene MET e la cescita invasiva delle cellule staminali del cancro 93
Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) 91
The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth 88
MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis 87
L'oncogene MET regola programmi cellulari che legano il cancro all'emostasi 86
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation 83
I recettori per i fattori di crescita 81
QUANDO FALLISCE LA REGOLAZIONE: L'INSORGENZA DEL CANCRO 80
Scatter factors and invasive growth. 80
Scatter factors in tumor progression 79
Scatter factor-dependent branching morphogenesis: structural and histological features 79
An mTOR feedback loop mediates the 'flare' ('rebound') response to MET tyrosine kinase inhibition 78
Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth. 78
Oncogenes, cancer, and haemostasis 77
Hepatocyte Growth Factor: A marker and a player in disseminated intravascular coagulation 76
The integrated stress response drives MET oncogene overexpression in cancers 53
Totale 14.453
Categoria #
all - tutte 41.168
article - articoli 0
book - libri 0
conference - conferenze 2.612
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.305 0 111 100 103 102 71 103 92 81 69 251 222
2022/20231.804 176 121 80 161 153 341 156 151 194 46 140 85
2023/20241.145 171 144 60 85 77 161 61 74 18 78 100 116
2024/20252.088 37 111 117 194 498 159 71 102 197 180 150 272
2025/20263.780 354 155 213 357 360 153 556 144 267 509 192 520
2026/2027357 183 174 0 0 0 0 0 0 0 0 0 0
Totale 14.453